Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212787 | SCV000170869 | benign | not specified | 2014-04-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000127308 | SCV000213168 | likely benign | Hereditary cancer-predisposing syndrome | 2014-09-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000206142 | SCV000259459 | likely benign | Familial cancer of breast | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000206142 | SCV000488520 | likely benign | Familial cancer of breast | 2016-04-20 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000127308 | SCV000911192 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-25 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001800420 | SCV002047285 | likely benign | not provided | 2023-08-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000212787 | SCV002103991 | likely benign | not specified | 2022-02-28 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225411 | SCV002504939 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000127308 | SCV002530599 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-19 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002498627 | SCV002809671 | likely benign | Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3 | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000206142 | SCV004019617 | benign | Familial cancer of breast | 2023-03-31 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Ce |
RCV001800420 | SCV005329770 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | PALB2: BP4, BP7 |